GGrantIndex
← Leaderboards

Andrew D Wells

Children'S Hosp Of Philadelphia

Google Scholar ↗PubMed ↗ORCID ↗
$15,150,358
Attributed
$20,228,241
Total exposure
10
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY2005–25
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$20,228,241 · 10

By mechanism

R01$16,292,976 · 4
P01$1,898,220 · 1
R21$1,461,500 · 3
R56$293,125 · 1
K01$282,420 · 1

Top collaborators

Most similar at Children'S Hosp Of Philadelphia

Same institution · by research overlap

Others in their field

Top investigators on “T-Lymphocyte”

Research focus

T-LymphocyteGene ExpressionGenesRegulatory T-LymphocyteImmuneAutoimmune DiseasesGenetic TranscriptionResponseInterleukin-2MediatingRegulationT Cell DifferentiationBaseLinkInflammatoryIn VivoOrgan TransplantationCell PhysiologyChromatinIn VitroMutantCd4 Positive T LymphocytesImmune ToleranceGenetic

Grant awards (46)

Mechanisms of autoimmune disease risk in IL2/IL2RA-dependent immune tolerance$731,602
R01 · FY2025 · AI · contact PI
Mechanisms of autoimmune disease risk in IL2/IL2RA-dependent immune tolerance$754,229
R01 · FY2024 · AI · contact PI
HIPK1: a new immunomodulatory target for SLE$222,500
R21 · FY2024 · AI · contact PI
Mechanisms of autoimmune disease risk in IL2/IL2RA-dependent immune tolerance$754,229
R01 · FY2023 · AI · contact PI
HIPK1: a new immunomodulatory target for SLE$267,000
R21 · FY2023 · AI · contact PI
Functional Mechanisms of T1D Risk Variants and their Target Genes using 3D Epigenomics and Single Cell Approaches$977,362
R01 · FY2022 · DK
Mechanisms of autoimmune disease risk in IL2/IL2RA-dependent immune tolerance$754,229
R01 · FY2022 · AI · contact PI
Functional Mechanisms of T1D Risk Variants and their Target Genes using 3D Epigenomics and Single Cell Approaches$979,027
R01 · FY2021 · DK
Mechanisms of autoimmune disease risk in IL2/IL2RA-dependent immune tolerance$773,229
R01 · FY2021 · AI · contact PI
Functional Mechanisms of T1D Risk Variants and their Target Genes using 3D Epigenomics and Single Cell Approaches$1,390,253
R01 · FY2020 · DK
Cyclin-dependent kinases: Novel switches in anergy and targets for tolerance$420,000
R01 · FY2020 · AI · contact PI
Functional Mechanisms of T1D Risk Variants and their Target Genes using 3D Epigenomics and Single Cell Approaches$1,035,319
R01 · FY2019 · DK
Cyclin-dependent kinases: Novel switches in anergy and targets for tolerance$420,000
R01 · FY2019 · AI · contact PI
Functional Mechanisms of T1D Risk Variants and their Target Genes using 3D Epigenomics and Single Cell Approaches$409,225
R01 · FY2019 · DK
Cyclin-dependent kinases: Novel switches in anergy and targets for tolerance$420,000
R01 · FY2018 · AI · contact PI
Cyclin-dependent kinases: Novel switches in anergy and targets for tolerance$420,000
R01 · FY2017 · AI · contact PI
Cyclin-dependent kinases: Novel switches in anergy and targets for tolerance$420,000
R01 · FY2016 · AI · contact PI
Intergenic cis regulatory elements in the control of IL-2 and IL-21$210,000
R21 · FY2015 · AI · contact PI
Cyclin-dependent kinases: Novel switches in anergy and targets for tolerance$293,125
R56 · FY2014 · AI · contact PI
Intergenic cis regulatory elements in the control of IL-2 and IL-21$252,000
R21 · FY2014 · AI · contact PI
Cyclin-dependent kinases: Novel switches in anergy and targets for tolerance$403,066
R01 · FY2012 · AI · contact PI
Effect of IPEX mutations on FOXP3 DNA binding and chromatin remodeling$379,130
P01 · FY2012 · AI · contact PI
Regulation of Foxp3 Function$362,760
R01 · FY2012 · AI · contact PI
Cyclin-dependent kinases: Novel switches in anergy and targets for tolerance$403,066
R01 · FY2011 · AI · contact PI
Effect of IPEX mutations on FOXP3 DNA binding and chromatin remodeling$389,263
P01 · FY2011 · AI · contact PI
Regulation of Foxp3 Function$362,760
R01 · FY2011 · AI · contact PI
Cyclin-dependent kinases: Novel switches in anergy and targets for tolerance$407,138
R01 · FY2010 · AI · contact PI
Effect of IPEX mutations on FOXP3 DNA binding and chromatin remodeling$373,494
P01 · FY2010 · AI · contact PI
Regulation of Foxp3 Function$366,424
R01 · FY2010 · AI · contact PI
Cyclin-dependent kinases: Novel switches in anergy and targets for tolerance$411,250
R01 · FY2009 · AI · contact PI
Effect of IPEX mutations on FOXP3 DNA binding and chromatin remodeling$378,572
P01 · FY2009 · AI · contact PI
Regulation of Foxp3 Function$370,125
R01 · FY2009 · AI · contact PI
Regulation of Foxp3 Function$155,780
R01 · FY2009 · AI · contact PI
Cyclin-dependent kinases: Novel switches in anergy and targets for tolerance$411,250
R01 · FY2008 · AI · contact PI
Effect of IPEX mutations on FOXP3 DNA binding and chromatin remodeling$377,761
P01 · FY2008 · AI · contact PI
Regulation of Foxp3 Function$370,688
R01 · FY2008 · AI · contact PI
Growth Factor Signaling, Cell Division and T cell Anergy$332,010
R01 · FY2006 · AI · contact PI
Growth Factor Signaling, Cell Division and T cell Anergy$340,000
R01 · FY2005 · AI
Role of Ikaros in IL-2 gene expression and T cell anergy$255,000
R21 · FY2005 · AI
Growth Factor Signaling, Cell Division and T cell Anergy$340,000
R01 · FY2004 · AI
Role of Ikaros in IL-2 gene expression and T cell anergy$255,000
R21 · FY2004 · AI
Growth Factor Signaling, Cell Division and T cell Anergy$291,955
R01 · FY2003 · AI
Growth Factor Signaling, Cell Division and T cell Anergy$306,000
R01 · FY2002 · AI
T CELL DIVISION, SURVIVAL AND MEMORY IN TRANSPLANTATION$97,740
K01 · FY2002 · DK
T CELL DIVISION, SURVIVAL AND MEMORY IN TRANSPLANTATION$92,340
K01 · FY2001 · DK
T CELL DIVISION, SURVIVAL AND MEMORY IN TRANSPLANTATION$92,340
K01 · FY2000 · DK